Root Coverage with Tunneling Technique with Connective Tissue Versus Coronal Advancement Flap Technique.
Launched by LUIS ALBERTO CHAUCA BAJAÑA · Jan 18, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different surgical techniques for treating gum recession, which is when the gums pull back from the teeth, exposing the roots. The two methods being compared are the tunneling technique and the coronal advancement flap technique. Researchers want to see which method works better in terms of improving gum coverage, the appearance of the gums, and how patients feel about the results. They will also keep track of any discomfort or complications that may arise from each technique.
To participate in this study, you need to be a non-smoker, in good overall health, and have specific types of gum recession without any active gum disease. You should also have at least four affected areas in your upper jaw where the gums have receded. If you join the study, you can expect to receive one of the two treatments and will be monitored afterward to assess your recovery and results. This research aims to help dental professionals choose the best treatment for patients with gum recession.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Non-smoking
- • No systemic diseases, no pregnancy
- • No active periodontal disease
- • Bacterial plaque and bleeding Score ≤9%.
- • No medication that interferes with periodontal tissue health or scarring.
- • Teeth without root canal treatments
- • No contraindication to periodontal surgery
- • Presence of at least one type I and II Miller O RT1 - RT2 recession defect with at least 4 recessions in the upper or lower jaw that clearly shows the amelocementary limit.
- • Work will be done on upper central incisors, upper lateral incisors, upper canines and upper premolars.
- • For the coronal advancement technique, multiple or unitary gingival recessions will be used
- Exclusion Criteria:
- • SMOKING PATIENT
- • PATIENT WITH A SYSTEMIC DISEASE
- • WITH PERIODONTAL DISEASE
- • GINGIVAL RECESSION CLASS III OR RT3
- • PATIENT WITH EDENTULISM
- • PATIENT WITHOUT AMELOCEMENTARY LIMIT
About Luis Alberto Chauca Bajaña
Luis Alberto Chauca Bajaña is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient care through innovative studies. With a focus on ethical practices and regulatory compliance, he leads initiatives that explore novel therapies and treatment modalities across various therapeutic areas. Leveraging extensive experience in clinical development, he collaborates with healthcare professionals and research organizations to ensure the successful design and execution of clinical trials, ultimately aiming to contribute valuable insights to the medical community and enhance therapeutic options for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Guayaquil, Guayas, Ecuador
Patients applied
Trial Officials
LUIS CHAUCA, PHD (C)
Principal Investigator
Universidad de Guayaquil
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported